U.S. Life Sciences Stock News

If you are wondering whether Solaris Energy Infrastructure is priced fairly after its run, this article focuses on what the current valuation might be telling you about the stock. The share price last closed at US$77.45, with returns of 8.8% over 7 days, 40.4% over 30 days, 54.1% year to date and 259.8% over 1 year, as well as a very large 3 year gain and more than 7x over 5 years. These moves have drawn attention to Solaris Energy Infrastructure, and recent coverage has focused on how the...

Ingram Micro Holding (NYSE:INGM) is seeing a substantial secondary offering by its principal shareholder, an affiliate of Platinum Equity, shifting a meaningful block of ownership. The company has authorized a $30 million share repurchase from the underwriters in connection with this offering, signaling active capital management around the transaction. Separately, Ingram Micro has been selected as a global distribution partner for Huntress, a cybersecurity platform, expanding its reach in...

If you are wondering whether Cabot is trading at an attractive price today, or if the recent enthusiasm already reflects its value, this breakdown will help you put the current share price in context. Cabot's stock recently closed at US$82.41, with returns of 8.8% over the past week, 10.8% over the past month, 22.9% year to date and 15.7% over the past year, which can influence how you think about upside and risk. Recent coverage around Cabot has focused on giving investors evergreen context...

It's been a mediocre week for Bumble Inc. ( NASDAQ:BMBL ) shareholders, with the stock dropping 19% to US$3.43 in the...

If you are wondering whether Alkami Technology at around US$16.75 is starting to look like value or still carries more risk than reward, the recent price history gives you a useful starting point. The stock has moved 2.0% over the last 7 days, is roughly flat over 30 days with a 0.2% decline, but is down 26.1% year to date and 40.2% over the past year, set against a 28.8% gain over 3 years and a 48.7% decline over 5 years. These mixed returns have kept attention on how the business is being...

Wondering if Patrick Industries, at a last close of US$95.90, offers good value or if the easy money has already been made? These valuation checks aim to give you a clearer picture before you decide your next move. The stock has had a mixed run, with a 2.8% return over the last 7 days, a 15.8% decline over 30 days, a 20.0% return over 1 year, and 132.9% over 3 years. Recent news coverage has focused on Patrick Industries as part of broader discussions around the Auto Components sector and...

If you are wondering whether Automatic Data Processing (ADP) looks attractively priced after a rough patch, this article will help you assess what you might really be paying for with the stock. At a last close of US$207.20, ADP's share price reflects a 3.7% decline over the past week, a 1.4% gain over the past month, and returns of an 18.1% decline year to date and a 30.4% decline over the past year. Those moves have kept ADP on many investors' watchlists, with recent headlines keeping...

Wondering if Edison International is fairly priced at around US$68.80, or if the market is missing something about this utility stock's potential value. The stock recently closed at US$68.80, with returns of 1.3% over 7 days, a 6.5% decline over 30 days, 12.9% year to date, 30.7% over 1 year, 7.5% over 3 years and 53.4% over 5 years, giving you a mixed picture to interpret. Recent attention on Edison International has focused on how the company fits into the broader US utilities sector and...

It's shaping up to be a tough period for ONE Gas, Inc. ( NYSE:OGS ), which a week ago released some disappointing...

Wondering if AppLovin at around US$468.83 is still offering value or if most of the opportunity is already reflected in the price? This article walks through the key numbers so you can judge how the stock stacks up on valuation. The stock has returned 5.7% over the past week and 13.6% over the past month, while the year to date return stands at a 24.2% decline and the 1 year return is 54.5%, with a very large gain over 3 years. Recent news around AppLovin has focused on its position in...

American Public University System, part of American Public Education (NasdaqGS:APEI), is preparing its 30th annual commencement. The ceremony includes a record graduating class for APUS. APUS is adding a dedicated doctoral hooding event and expanded graduate celebrations. Additional ceremonies and student recognition initiatives are planned around the commencement. American Public Education, through APUS, focuses on online higher education for adult learners, including military and public...

TG Therapeutics (TGTX) has just posted Q1 2026 results with revenue of US$204.9 million, basic EPS of US$0.14 and net income of US$19.8 million, putting fresh numbers behind a stock that last closed at US$41.97. The company has seen total revenue move from US$108.2 million in Q4 2024 to US$120.9 million in Q1 2025 and then to US$204.9 million in Q1 2026, while trailing twelve month basic EPS is reported at US$3.21 alongside trailing net profit margin of 66%. Taken together, these figures...

If you are wondering whether Williams Companies at around US$73.76 is offering good value or asking too much, the key is to look past the headline price and into how it stacks up on a few core valuation checks. The stock has returned 0.6% over the last 7 days, 1.6% over the last 30 days, 21.2% year to date and 29.2% over the past year, so the current price already reflects a meaningful shift in how the market views the company. Recent news coverage has focused on Williams Companies as a...

Q1 2026 results in focus SolarEdge Technologies (SEDG) opened 2026 with Q1 revenue of US$310.5 million and a basic EPS loss of US$0.94, alongside trailing twelve month revenue of US$1.28 billion and a basic EPS loss of US$5.99. Over recent quarters the company has seen revenue move from US$196.2 million in Q4 2024 to between roughly US$219.5 million and US$340.2 million through 2025. Over the same period, quarterly basic EPS has ranged from a loss of US$0.84 to a loss of US$5.00, setting up...

If you are wondering whether Fortrea Holdings at US$15.64 is still offering value after a strong run, or if you are late to the story, this article focuses on what the current price might be implying. The stock has moved sharply, with returns of 48.1% over the last 7 days, 73.6% over the last 30 days and 177.8% over the last year, although year to date it sits at a 7.0% decline. Recent market attention has centered on Fortrea's position within the life sciences and pharmaceutical services...

Investors may be wondering whether Curtiss-Wright still offers good value after a strong share price performance, or if the current price has moved ahead of what the underlying business might justify. The stock last closed at US$742.89, with returns of 6.7% over 7 days, 6.3% over 30 days, 29.8% year to date and 105.5% over 1 year. These figures naturally raise questions about how much of the company’s story may already be reflected in the price. Recent attention on Curtiss-Wright has...

Ichor Holdings (ICHR) opened Q1 2026 with revenue of US$256.1 million and a basic EPS loss of US$0.07, alongside a trailing 12 month basic EPS loss of US$1.47 on revenue of US$959.3 million. Over recent quarters, the company has seen revenue move from US$244.5 million and a basic EPS loss of US$0.13 in Q1 2025 to US$223.6 million with a basic EPS loss of US$0.46 in Q4 2025, setting up this latest print as part of a wider stretch of loss making results. For investors, the key question now is...

Arrow International issued a nationwide recall of certain dialysis catheter kits that include Merit Medical’s 16F Dual-Valved Splittable Sheath Introducers. The recall is linked to a design defect that may prevent the sheath from splitting as intended during use. The action centers on product quality and regulatory compliance risks that could affect NasdaqGS:MMSI. Merit Medical Systems (NasdaqGS:MMSI) supplies devices used across interventional cardiology, radiology, and vascular access,...

The United States market has seen a robust performance, climbing 3.2% in the last week and rising 31% over the past year, with earnings projected to grow by 16% annually. In this thriving environment, identifying stocks that are trading below their intrinsic value can offer potential opportunities for investors looking to capitalize on undervalued assets.

Over the last 7 days, the United States market has risen by 3.2%, contributing to a remarkable 31% increase over the past year, with earnings forecasted to grow by 16% annually. In this thriving environment, growth companies with high insider ownership often attract attention as they suggest confidence from those closest to the business and potential for sustained performance.

Over the last 7 days, the United States market has risen 3.2%, and over the past year, it has climbed an impressive 31%, with earnings forecasted to grow by 16% annually. In such a robust market environment, identifying stocks with strong financials can be key to capturing growth potential. Although the term "penny stocks" might seem outdated, these investments in smaller or newer companies continue to offer intriguing opportunities for those seeking affordability and potential growth.

Over the last 7 days, the United States market has risen by 3.2% and is up 31% over the last year, with earnings forecast to grow by 16% annually. In this thriving environment, identifying stocks that are not only poised for growth but also remain underappreciated can offer unique opportunities for investors seeking undiscovered gems.

The United States market has experienced a robust performance recently, climbing 3.2% in the last week and rising 31% over the past year, with earnings projected to grow by 16% annually. In this thriving environment, dividend stocks can be an attractive option for investors seeking steady income and potential growth, as they offer regular payouts while benefiting from the overall market's upward momentum.

For investors wondering if Abercrombie & Fitch is still good value after its recent run and subsequent pullbacks, this piece breaks down what the current share price might be implying about the stock. The stock last closed at US$79.40, with returns of 14.0% over the past year. Shorter-term moves include a 5.6% decline over 7 days, an 18.5% decline over 30 days, and a 35.8% decline year to date. Recent price action has put extra attention on whether earlier gains are fully justified or if the...